Ophthalmic surgery in prion diseases

Emerging Infectious Diseases

Volumn 13, Issue 1, 2007, Pages 162-164

  Hamaguchi, Tsuyoshi ^a,f   Noguchi Shinohara, Moeko ^a   Nakamura, Yosikazu ^b,g   Sato, Takeshi ^c,g   Kitamoto, Tetsuyuki ^d,g   Mizusawa, Hidehiro ^e,g   Yamada, Masahito ^a,g  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^g Creutzfeldt Jakob Disease Surveillance Committee   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE SURVEILLANCE; EYE SURGERY; FEMALE; HUMAN; INSTRUMENT STERILIZATION; JAPAN; MAJOR CLINICAL STUDY; MALE; SURGICAL INSTRUMENT;

EID: 33846093065     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1301.061004     Document Type: Article

References (15)

1. Kropp S, Schulz-Schaeffer WJ, Finkenstaedt M, Riedemann C, Windl O, Steinhoff BJ, et al. The Heidenhain variant of Creutzfeldt-Jakob disease. Arch Neurol. 1999;56:55-61.
2. Lueck CJ, McIlwain GG, Zeidler M. Creutzfeldt-Jakob disease and the eye. II. Ophthalmic and neuro-ophthalmic features. Eye. 2000;14:291-300.
3. Cooper SA, Murray KL, Heath CA, Will RG, Knight RSG. Isolated visual symptoms at onset in sporadic Creutzfeldt-Jakob disease: the clinical phenotype of the "Heidenhain variant." Br J Ophthalmol. 2005;89:1341-2.
4. Tullo A. Creutzfeldt-Jakob disease and eye surgery - new disease, old disease. J Cataract Refract Surg. 2003;29:629-31.
5. Head MW, Northcott V, Rennison K, Ritchie D, McCardle L, Bunn TJ, et al. Prion protein accumulation in eyes of patients with sporadic and variant Creutzfeldt-Jakob disease. Invest Ophthalmol Vis Sci. 2003;44:342-6.
6. Head MW, Peden AH, Yull HM, Ritchie DL, Bonshek RE, Tullo AB, et al. Abnormal prion protein in the retina of the most commonly occurring subtype of sporadic Creutzfeldt-Jakob disease. Br J Ophthalmol. 2005;89:1131-3.
7. Duffy P, Wolf J, Collins G, DeVoe AG, Sreeten B, Cowen D. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med. 1974;290:692-3.
8. Heckmann JG, Lang CJG, Petruch F, Druschky A, Erb C, Brown P, et al. Transmission of Creutzfeldt-Jakob disease via a corneal transplant. J Neurol Neurosurg Psychiatry. 1997;63:388-90.
9. World Health Organization (WHO). WHO infection control guidelines for transmissible spongiform encephalopathies. Report of a WHO consultation, Geneva, Switzerland, 1999 March 23-26. Geneva: WHO; 1999. Available from http://www.who.int/csr/resources/publications/bse/WHO_CDS_CSR_APH_2000_3/en/
10. Masters CL, Harris JO, Gajdusek DC, Gibbs CJ Jr, Bernoulli C, Asher DM. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol. 1979;5:177-88.
11. World Health Organization (WHO). The revision of the variant Creutzfeldt-Jakob (vCJD) case definition. Report of a WHO consultation. Edinburgh, United Kingdom, 2001 17 May (WHO/CDS/CSR/EPH/2001.5). Geneva: WHO; 2001.
12. Taylor DM. Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J. 2000;159:10-7.
13. S-Juan P. Ward HJ, De Silva R, Knight RS, Will RG. Ophthalmic surgery and Creutzfeldt-Jakob disease. Br J Ophthalmol. 2004;88:446-9.
14. Brenner MH, Curbow B, Javitt JC, Legro MW, Sommer A. Vision change and quality of life in the elderly. Response to cataract surgery and treatment of other chronic ocular conditions. Arch Ophthalmol. 1993;111:680-5.
15. Tamura H, Tsukamoto H, Mukai S, Kato T, Minamoto A, Ohno Y, et al. Improvement in cognitive impairment after cataract surgery in elderly patients. J Cataract Refract Surg. 2004;30:598-602.